Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$719,255.00
Oct 1, 2013
Role of the nuclear pore complex in genome organization and gene silencing
$650,620.00
Oct 1, 2013
Dissecting a novel gene regulatory function for histone H2B ubiquitylation
$554,057.00
Oct 1, 2013
Clonal evolution of medulloblastoma BTICs (brain tumor initiating cells) in response to therapy: Discovering the refractory BTIC population through genes regulating stem cell self-renewal
$395,309.00
Oct 1, 2013
Differential effects of saturated and polyunsaturated fatty acids on chylomicron secretion and expression of key genes and proteins that regulate intestinal lipid metabolism in men with dyslipidemia associated with insulin-resistance
$704,454.00
Oct 1, 2013
Action of the CCR4-NOT complex in mammalian gene silencing networks
$709,705.00
Oct 1, 2013
Identify New Genes for Recurrent Molar Pregnancies and Characterize mechanisms of mole formation
$364,376.00
Oct 1, 2013
Defining the causes of heterogeneous riboucleotide reductase gene transcription in response to DNA damage and anti-cancer drugs
$528,516.00
Oct 1, 2013
Coordinating DNA deamination, double strand break and repair to prevent genomic instability during antibody gene diversification.
$300,000.00
Oct 1, 2013
Uncovering the molecular pathways that drive resistance to targeted cancer therapies through functional genetics
$99,474.00
Oct 1, 2013
Joining well-characterized phenotype and genetic exposures with powerful statistical models to understand gene-environment interactions in metabolic syndrome